Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas

American Journal of Pathology

Volumn 156, Issue 2, 2000, Pages 501-507

  Greiner, Axel ^a   Müller, Kerstin B ^b   Hess, Jochen ^b   Pfeffer, Klaus ^c   Müller Hermelink, H Konrad ^a   Wirth, Thomas ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Inst Med Mikrobiol Immunol Hyg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 4; LYMPHOTOXIN; PROTEIN; PROTEIN BCL 6; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033888314     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64754-2     Document Type: Article

References (48)

1. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity
2. Immunoglobulin gene transcription
3. Activation of octamer-containing promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and requirement of an additional B-cell-specific component for optimal transcription of immunoglobulin promoters
4. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors
5. Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity
6. Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities
7. A B-cell coactivator of octamer-binding transcription factors
8. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer proteins
9. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B
10. Functional characterization of the murine homolog of the B-cell-specific coactivator BOB.1/OBF.1
11. Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B
12. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with the Oct-1/Oct-2 factors, leading to differential promoter activation
13. Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1
14. Coordinate suppression of myeloma-specific genes and expression of fibroblast-specific genes in myeloma x fibroblast somatic hybrids
15. Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells
16. OCA-B integrates B cell antigen receptor-, CD40L-, and IL 4-mediated signals for the germinal center pathway of B cell development
17. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response, and germinal centre formation
18. The B-Cell-Specific transcription coactivator OCA-B/OBF-1/ Bob-1 is essential for normal production of immunoglobulin isotypes
19. Lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCAB/OBF1
20. A revised European-American classification of lymphoid neoplasms: A proposal from the international Lymphoma Study Group
21. Vascular autoantibodies in amyotrophic lateral sclerosis
22. Immunohistochemical analysis of proliferating and antigen-presenting cells in rheumatoid synovial tissue
23. Memory B cells are biased towards terminal differentiation: A strategy that may prevent repertoire freezing
24. Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling, and Th2-type cytokines for in vitro growth and differentiation
25. IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures
26. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific, and inducible gene activation
27. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells
28. The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching
29. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
30. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues
31. The NF-κB/Rel system of transcriptional activators
32. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling
33. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers
34. Control of inflammation, cytokine expression, and germinal center formation by BCL-6
35. Disruption of the Bcl6 gene results in an impaired germinal center formation
36. The BCL-6 proto-oncogene controls germinal-centre formation, and Th2-type inflammation
37. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma
38. LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients
39. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
40. Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma
41. Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation
42. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas
43. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor
44. The B cell transcriptional coactivator BOB1/OBF1 gene fuses to the LAZ3/ BCL6 gene by t(3;11)(q27;q23.1) chromosomal translocation in a B cell leukaemia line (Karpas 231)
45. Heterogeneity of breakpoints at the transcriptional co-activator gene, BOB-1, in lymphoproliferative disease
46. BCL-6 protein is expressed in germinal-center B cells
47. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts
48. BCL-6 expression during B-cell activation